These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

856 related items for PubMed ID: 19262210

  • 1. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients.
    Romano S, Necozione S, Guarracini L, Fratini S, Cisternino P, di Orio F, Penco M.
    J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):238-44. PubMed ID: 19262210
    [Abstract] [Full Text] [Related]

  • 2. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M, Bozkurt A, Yildiray-Sahin D, Unal I, Acartürk E.
    Cardiol J; 2009 Mar; 16(1):43-9. PubMed ID: 19130415
    [Abstract] [Full Text] [Related]

  • 3. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.
    Vanderheyden M, Bartunek, Claeys G, Manoharan G, Beckers JF, Ide L.
    Clin Biochem; 2006 Jun; 39(6):640-5. PubMed ID: 16516185
    [Abstract] [Full Text] [Related]

  • 4. NT-proBNP levels in the evaluation of right ventricular dysfunction in patients with coronary artery disease and abnormal left ventricular wall motion: a magnetic resonance imaging study.
    Krittayaphong R, Boonyasirinant T, Saiviroonporn P, Udompunturak S.
    Coron Artery Dis; 2008 Nov; 19(7):481-7. PubMed ID: 18923244
    [Abstract] [Full Text] [Related]

  • 5. The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation.
    Shelton RJ, Clark AL, Goode K, Rigby AS, Cleland JG.
    Eur Heart J; 2006 Oct; 27(19):2353-61. PubMed ID: 16952921
    [Abstract] [Full Text] [Related]

  • 6. The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements.
    Tschöpe C, Kasner M, Westermann D, Gaub R, Poller WC, Schultheiss HP.
    Eur Heart J; 2005 Nov; 26(21):2277-84. PubMed ID: 16014646
    [Abstract] [Full Text] [Related]

  • 7. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E.
    Am J Cardiol; 2008 Sep 15; 102(6):733-7. PubMed ID: 18773998
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S, Kümpers P, Seidler V, Biertz F, Haller H, Fliser D.
    Nephrol Dial Transplant; 2008 Apr 15; 23(4):1370-7. PubMed ID: 18089624
    [Abstract] [Full Text] [Related]

  • 9. N-terminal pro-B-type natriuretic peptide as a predictor of repeat coronary revascularization.
    Sir JJ, Chung WY, Hwang SJ, Kang HJ, Cho YS, Koo BK, Chae IH, Choi DJ, Kim HS, Sohn DW, Kim CH, Oh BH, Park YB, Choi YS.
    Int J Cardiol; 2008 Jun 06; 126(3):322-32. PubMed ID: 17544525
    [Abstract] [Full Text] [Related]

  • 10. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
    Elmas E, Brueckmann M, Lang S, Kälsch T, Haghi D, Sueselbeck T, Dempfle CE, Borggrefe M.
    Int J Cardiol; 2008 Aug 18; 128(2):244-9. PubMed ID: 17673312
    [Abstract] [Full Text] [Related]

  • 11. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
    Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV.
    J Heart Lung Transplant; 2007 May 18; 26(5):516-21. PubMed ID: 17449423
    [Abstract] [Full Text] [Related]

  • 12. Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction.
    Campbell DJ, Mitchelhill KI, Schlicht SM, Booth RJ.
    J Card Fail; 2000 Jun 18; 6(2):130-9. PubMed ID: 10908087
    [Abstract] [Full Text] [Related]

  • 13. N-terminal proB-type natriuretic peptide levels aid the diagnosis of left ventricular dysfunction in patients with severe acute exacerbations of chronic obstructive pulmonary disease and renal dysfunction.
    Ouanes I, Jalloul F, Ayed S, Dachraoui F, Ouanes-Besbes L, Fekih Hassen M, Elatrous S, Abroug F.
    Respirology; 2012 May 18; 17(4):660-6. PubMed ID: 22348741
    [Abstract] [Full Text] [Related]

  • 14. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.
    J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563
    [Abstract] [Full Text] [Related]

  • 15. Comparison of N-terminal pro-B-type natriuretic peptide levels in critically ill children with sepsis versus acute left ventricular dysfunction.
    Fried I, Bar-Oz B, Algur N, Fried E, Gavri S, Yatsiv I, Perles Z, Rein AJ, Zonis Z, Bass R, Nir A.
    Pediatrics; 2006 Oct 13; 118(4):e1165-8. PubMed ID: 16966393
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Screening for asymptomatic left ventricular systolic dysfunction in high-risk patients. Preliminary experience with a program based on the use of ECG and natriuretic peptide].
    Tarantini L, Cioffi G, Di Lenarda A, Valle R, Pulignano G, Del Sindaco D, Frigo G, Soravia G, Tessier R, Catania G.
    G Ital Cardiol (Rome); 2008 Dec 13; 9(12):835-43. PubMed ID: 19119693
    [Abstract] [Full Text] [Related]

  • 19. Obese and nonobese patients with essential hypertension show similar N-terminal proBNP plasma levels.
    Cortés R, Otero MR, Morillas P, Roselló-Lletí E, Grigorian L, Martínez-Dolz L, de Burgos FG, Calabuig JR, Soria F, Lozano T, Portolés M, Bertomeu V.
    Am J Hypertens; 2008 Jul 13; 21(7):820-5. PubMed ID: 18443568
    [Abstract] [Full Text] [Related]

  • 20. Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction: favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide.
    Giallauria F, Cirillo P, Lucci R, Pacileo M, De Lorenzo A, D'Agostino M, Moschella S, Psaroudaki M, Del Forno D, Orio F, Vitale DF, Chiariello M, Vigorito C.
    Eur J Cardiovasc Prev Rehabil; 2008 Feb 13; 15(1):113-8. PubMed ID: 18277196
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.